June 2017
Volume 58, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2017
Enhancing pterygium fibroblasts culture: a serial explant technique using extracellular matrix coating
Author Affiliations & Notes
  • Denise Loya
    Ophthalmology and Visual Sciences Institute, School of Medicine of the Tecnologico de Monterrey, Monterrey, Nuevo Leon, Mexico
  • Eduardo Camacho-Martinez
    Ophthalmology and Visual Sciences Institute, School of Medicine of the Tecnologico de Monterrey, Monterrey, Nuevo Leon, Mexico
  • Judith Zavala
    Ophthalmology and Visual Sciences Institute, School of Medicine of the Tecnologico de Monterrey, Monterrey, Nuevo Leon, Mexico
  • Julio C Hernandez
    Ophthalmology and Visual Sciences Institute, School of Medicine of the Tecnologico de Monterrey, Monterrey, Nuevo Leon, Mexico
  • Jorge E Valdez
    Ophthalmology and Visual Sciences Institute, School of Medicine of the Tecnologico de Monterrey, Monterrey, Nuevo Leon, Mexico
  • Footnotes
    Commercial Relationships   Denise Loya, None; Eduardo Camacho-Martinez, None; Judith Zavala, None; Julio Hernandez, None; Jorge Valdez, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2017, Vol.58, 3939. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to Subscribers Only
      Sign In or Create an Account ×
    • Get Citation

      Denise Loya, Eduardo Camacho-Martinez, Judith Zavala, Julio C Hernandez, Jorge E Valdez; Enhancing pterygium fibroblasts culture: a serial explant technique using extracellular matrix coating. Invest. Ophthalmol. Vis. Sci. 2017;58(8):3939.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The lack of commercial cell lines and the need of primary tissue explants to culture pterygium fibroblasts are obstacles in the study of pterygia. The use of extracellular matrix for culture optimization with encouraging results has been described for epithelial cells but not for fibroblasts. The aim of this study is to analyze the feasibility of a serial explant culture technique using extracellular matrix coating as a viable option for enhancing human pterygia fibroblasts culture for its subsequent use in research

Methods : Pterygium tissue was obtained from the pathology department of Hospital San José Tecnológico de Monterrey (Monterrey, México) and fractionated into small pieces of approximately 3mm2 each. Tissue was cultured in a 24 well microplate previously coated with 20µl of extracellular matrix based hydrogel (Matrigel, Corning), and just enough culture medium D-MEM F-12 (Gibco, Ref: 12400-016) to cover the explant and the extracellular matrix. Explants were incubated under standard conditions (37 C, 5% CO2) with medium being refreshed twice per week. Once cells were confluent subculture and explant transfer was done. Cells from each well were subcultured in 3 different wells in a new coated 24 well microplate. Explants were also transferred to new 24 well microplates coated with extracellular matrix based hydrogel

Results : After the primary culture, a total of four explant transfers were done. Confluence was achieved 27 days later for the primary culture, 4 weeks later for the first explant, 3 weeks later for the second and third explant transfers, and 4 weeks later for the fourth explant transfer. Subcultures were made for each plate once 80% confluence was achieved on a 1:3 basis, with subsequent passages as were needed. These passages showed decreased time period till confluence as they were expanded

Conclusions : The use of serial explants cultured with extracellular matrix coating proved to be a feasible way of increasing the number of cells that can be obtained from a single pterygium tissue sample. Fibroblastic cells obtained using this culture technique allowed preservation of cell morphology, replication rate and growth pattern in the explant transfers and subcultures. Further molecular characterization of pterygium fibroblasts will validate the stability of the obtained cells for their subsequent use in basic and translational research.

This is an abstract that was submitted for the 2017 ARVO Annual Meeting, held in Baltimore, MD, May 7-11, 2017.

 

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×